Specjalistyczna Praktyka Lekarska Dr Stanislaw Ochudlo
- Address
- ul. 3 Maja 34, 40-097 Katowice, Poland
Specjalistyczna Praktyka Lekarska Dr Stanislaw Ochudlo - Movement Disorders Research Center
This specialized medical practice focuses on clinical research in neurological movement disorders, with particular expertise in evaluating novel therapeutic interventions for involuntary movement conditions. The center has established itself as a key site for studying pharmacological treatments that target abnormal motor symptoms in patients with chronic neurological conditions.
- Tardive dyskinesia treatment development and long-term safety evaluation
- Tourette Syndrome therapeutic efficacy studies in adolescents and adults
- Advanced assessment of abnormal involuntary movements using standardized rating scales
The research center conducts comprehensive clinical trials ranging from Phase IIb multi-center studies to specialized double-blind, placebo-controlled investigations. Dr. Ochudlo's practice demonstrates particular proficiency in evaluating (+)-α-dihydrotetrabenazine and other emerging compounds, with emphasis on both short-term efficacy and long-term maintenance therapy protocols. The facility's capabilities include sophisticated monitoring of tic severity and abnormal involuntary movements, contributing valuable safety and tolerability data for novel neurological therapeutics.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Adeptio Pharmaceuticals Limited2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Adeptio Pharmaceuticals Limited2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Specjalistyczna Praktyka Lekarska Dr Stanislaw Ochudlo
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Gemlapodect in Adult and Adolescent Tourette Syndrome: A Double-Blind, Placebo-Controlled, Phase IIb Study | Noema Pharma AG | Phase II | Not Recruiting | Jul 2024 | Jan 2026 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| (2R,3R,11Br)-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-3-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol | 2 | Unknown | 2023-11-13 | 2024-04-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.